Coquitlam RCMP are continuing with investigative efforts to locate 25yr old male Arjun Purewal who is wanted for Breaching his Release Order.
BC Corrections notified police on Aug 26th that Purewal was breaching his release conditions and was last seen in Port Coquitlam in the area of Kebet Way and Coast Meridian Rd. He is known to police and considered dangerous.
He is described as:
25 years old
South Asian
5’9
150lbs
Black hair
Brown eyes
Anyone with information on the whereabouts of Arjun Purewal is asked to call 911 or the Coquitlam RCMP.
While early indications showed the virus was spread by droplets that settled on surfaces, Silas, president of the Canadian Federation of Nurses, urged health authorities to learn from the SARS outbreak of 2003 and take the highest level of precaution.
Though the rate of people who are hospitalized with Omicron is lower compared to the Delta variant, the forecast shows new daily hospital admissions will far exceed previous historical peaks due to the sheer number of cases.
Everything from who gets tested to who's most likely to contract the virus has changed with the latest wave of the pandemic, and that's posing distinct challenges for those who model its impact, says Caroline Colijn, an associate professor of mathematics at Simon Fraser University in British Columbia.
The Tory leader made his position known on Premier François Legault's proposal during a Facebook Liveevent late Thursday. Some of his MPs had already taken to social media to condemn the proposal as discriminatory, unethical and punishing to low-income earners.
Sheila Malcolmson, the minister of mental health and addictions, says the program dubbed the Tailgate Toolkit was developed on Vancouver Island last year in partnership with people in the industry who have experience with illicit drug use.
Canadian health leaders and some premiers have been publicly pressuring Health Canada to greenlight the medication, which prevents the SARS-CoV-2 virus that causes COVID-19 from reproducing within a patient's body. Pfizer's clinical trial showed for high-risk patients it prevented hospitalizations by about 90 per cent.
